Explore All 2734 Add-on Acquisition Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | February 19, 2015 |
| Target | M Diagnostics |
| Sector | Medical Products |
| Buyer(s) | Callitas Therapeutics |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2003 |
| Sector | Healthcare Services |
| Revenue | 1M CAD (2017) |
Callitas Health is focuses on providing biomedical technologies that improve the health and quality of life for people affected by obesity and diabetes. Callitas Health was founded in 2003 and is based in Vancouver, Canada.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 4 |
| Sector: Medical Products | 1 of 2 |
| Type: Add-on Acquisition | 1 of 3 |
| State: Alberta | 1 of 1 |
| Country: Canada | 1 of 2 |
| Year: 2015 | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-04-28 |
RX Global Capital
British Columbia, Canada RX Global Capital, Inc. is a developer of controllable pseudobezoars, an innovative method for non-invasive dynamic gastric volume reduction for weight loss, and several other medical applications. |
Buy | - |
